By proceeding, you agree to our Terms of Use and Privacy Policy.
Abcellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
17-19 January 2022
While a lot has changed since Peptalk was launched in 2001, our number one goal has always been the same: to serve and unite the biotherapeutics community. Peptalk is an annual gathering for key players in the industry that connects people from aroun
Event Ended
Hybrid
Paid
San Diego
02-06 May 2022
PEGS Boston Summit highlights a wide spectrum of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytical, immunogenicity, and more.
Boston
13-16 June 2022
As there is no substitute for in-person collaboration, BIO is back this year offering ample opportunities to connect with peers and those who can help you achieve your business goals. Check out our growing list of the events and receptions that BIO h
USA
27-29 June 2022
A focused 3-day meeting that delves into emerging technologies in antibody-based molecular engineering, novel & difficult targets, antibody-based therapeutics & a meeting place for experts working within engineering, computational tools and biotherap
Virtual
02-04 November 2022
Biologic drug discovery, development, manufacturing, pricing & market access, Clinical Trials. The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain.
Switzerland
Basel
14-16 November 2022
Network with more than 1,000 colleagues at PEGS Europe, the largest protein & antibody engineering event in Europe, which has been described as "the best biologics technology meeting in Europe.
Spain
Barcelona
13-16 December 2023
The latest science and research on antibody engineering, design and selection diving into critical topics including Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Deg